Materna closes $5 Million B3 financing to fuel growth

Materna Medical, a Mountain View, California-based OBGYN platform company, has successfully closed a $5 million B3 financing round. The investment was led by InnovaHealth Partners, Wavemaker360 Health, and Band of Angels, with participation from...

Materna closes $5 Million B3 financing to fuel growth

Materna Medical, a Mountain View, California-based OBGYN platform company, has successfully closed a $5 million B3 financing round. The investment was led by InnovaHealth...

Francis Medical announces publication of VAPOR 2 pivotal trial results

Francis Medical has published the initial report of its VAPOR 2 pivotal clinical study in The Journal of Urology, showcasing highly positive results for...

Zimmer Biomet to pay up to $140M for Iovera nerve therapy tech from Pacira BioSciences

Pacira BioSciences has agreed to sell its Iovera nerve therapy device to orthopedic giant Zimmer Biomet in a transaction valued at up to $140...

Novocure earns CE mark for Optune Pax pancreatic cancer treatment device

Novocure has successfully secured CE mark approval in Europe for its Optune Pax device, a wearable system designed to treat adults with locally advanced...
[hubspot type=form portal=25601863 id=e07d0241-001f-4840-8c08-6e5a4f7af710]

Finance

Funding

Clinical Trials

Francis Medical announces publication of VAPOR 2 pivotal trial results

Francis Medical has published the initial report of its VAPOR 2 pivotal clinical study in The Journal of Urology, showcasing highly positive results for...

Coherence Neuro begins first clinical study for BCI

Coherence Neuro has initiated its first clinical study of the investigational Cipher brain-computer interface (BCI), marking its transition into human testing. The study, led by...

Imperative Care reports SYMPHONY-PE trial data for pulmonary embolism

Imperative Care has reported results from a post-hoc analysis of the SYMPHONY-PE trial, evaluating the impact of early mechanical thrombectomy in patients with intermediate-risk...

VahatiCor enrolls first U.S. patient in SERRA-I clinical study of A-FLUX Reducer System

VahatiCor has enrolled the first U.S. patient in its SERRA-I early feasibility study, evaluating the investigational A-FLUX Reducer System® for patients with coronary microvascular...

Innovation

Regulatory Approvals

Materna closes $5 Million B3 financing to fuel growth

Materna Medical, a Mountain View, California-based OBGYN platform company, has successfully closed a $5 million B3 financing round. The investment was led by InnovaHealth...

Francis Medical announces publication of VAPOR 2 pivotal trial results

Francis Medical has published the initial report of its VAPOR 2 pivotal clinical study in The Journal of Urology, showcasing highly positive results for...

Zimmer Biomet to pay up to $140M for Iovera nerve therapy tech from Pacira BioSciences

Pacira BioSciences has agreed to sell its Iovera nerve therapy device to orthopedic giant Zimmer Biomet in a transaction valued at up to $140...

Novocure earns CE mark for Optune Pax pancreatic cancer treatment device

Novocure has successfully secured CE mark approval in Europe for its Optune Pax device, a wearable system designed to treat adults with locally advanced...

M&A

Archives

Latest articles